Who has invested in Cellanome?

DFJ Growth are named among the investors backing Cellanome.

Cellanome Funding: $150M Raised, Series B (2024)

Cellanome funding overview

Cellanome is based in Palo Alto, California. Cellanome has raised $150M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in February 2024. The round record for Cellanome runs through 2024; nothing later has been disclosed. Investors on record include DFJ Growth.

Cellanome at a glance

Total raised: $150M
Latest round: Series B
Latest round date: February 2024
Headquarters: Palo Alto, California
Notable investors: DFJ Growth

Frequently asked about Cellanome funding

How much has Cellanome raised?: Cellanome has raised $150M in total disclosed funding across the rounds on record.
Who has invested in Cellanome?: DFJ Growth are named among the investors backing Cellanome.
What was the latest Cellanome funding round?: The most recent disclosed round is a Series B, announced in February 2024.
Where is Cellanome based?: Cellanome is based in Palo Alto, California.
When did Cellanome last raise?: The last disclosed Cellanome round closed in February 2024 at Series B.

Every Cellanome figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Palo Alto at a similar stage.

Cellanome Funding: $150M Raised, Series B (2024)

Cellanome funding overview

Cellanome at a glance

Frequently asked about Cellanome funding

Companies related to Cellanome (35)

Browse related funding lists (6)